{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:46:39Z","timestamp":1794545199303,"version":"4.9.1"},"reference-count":46,"publisher":"BMJ","issue":"2","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"unspecified","delay-in-days":141,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"publisher","award":["2025J01090"],"award-info":[{"award-number":["2025J01090"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the innovation of science and Technology of Fujian province","award":["2021Y9116"],"award-info":[{"award-number":["2021Y9116"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82300803"],"award-info":[{"award-number":["82300803"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["Lupus Sci Med"],"accepted":{"date-parts":[[2025,10,18]]},"published-print":{"date-parts":[[2025,7]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>Lupus nephritis (LN) is a prevalent renal manifestation in patients with SLE, with kidney biopsy remaining the gold standard for evaluating disease activity. However, the invasive nature of biopsy and associated risks highlight the need for a non-invasive predictive tool. This study aimed to construct and validate predictive models for the activity index (AI) and tubulointerstitial lesions (TIL) in patients with LN as an alternative tool to assist clinicians in decision-making when kidney biopsy is not feasible.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We enrolled 266 patients with LN diagnosed by kidney biopsy from three centres, divided into a training cohort (n=213) and a validation cohort (n=53). Patients were stratified by AI and TIL scores: high AI (AI &gt;4), low AI (AI \u22644), high TIL (TIL &gt;4) and low TIL (TIL \u22644). Clinicopathological data were systematically collected. Multivariate logistic regression was employed to identify significant risk factors for high AI and TIL, and nomograms for individualised assessment were constructed. Model performance was evaluated using receiver operating characteristic curves, decision curve analysis, calibration plots and the Hosmer-Lemeshow test.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The key independent risk factors for high AI included lymphocyte count, haematuria, albumin, serum creatinine, complement 4 and antihistone antibodies. For high TIL, the risk factors included age, haemoglobin, platelet count, blood urea nitrogen and antiribosomal P antibodies. Both nomograms demonstrated favourable performance in terms of discrimination and calibration across both cohorts.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>The developed nomograms provide reliable, non-invasive tools for identifying patients with LN with high AI and TIL, which can improve clinical risk assessment and help guide more personalised management strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/lupus-2025-001726","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:35:13Z","timestamp":1763573713000},"page":"e001726","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":2,"title":["Development and validation of nomograms for predicting activity index and tubulointerstitial lesions in lupus nephritis: a multicentre study"],"prefix":"10.1136","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3513-6939","authenticated-orcid":false,"given":"Zishan","family":"Lin","sequence":"first","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingjing","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, the Affiliated Hospital of Putian University, Putian, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenfeng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Liang","sequence":"additional","affiliation":[{"name":"Department of Nephrology, The Second Hospital of Longyan, Longyan, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shidong","family":"Xie","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pathology, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianxin","family":"Wan","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caiming","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-545X","authenticated-orcid":false,"given":"Yanfang","family":"Xu","sequence":"additional","affiliation":[{"name":"Department of Nephrology, Blood Purification Research Center, the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Fujian Clinical Research Center for Metabolic Chronic Kidney Disease, The First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"},{"name":"Department of Nephrology, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou, Fujian, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"key":"2025111909350672000_12.2.e001726.1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41572-019-0141-9","article-title":"Lupus nephritis","volume":"6","author":"Anders","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"2025111909350672000_12.2.e001726.2","first-page":"1011","article-title":"Systemic lupus erythematosus, lupus nephritis and end-stage renal disease: a pragmatic review mapping disease severity and progression","volume":"29","author":"Mahajan","year":"2020","journal-title":"Lupus (Los Angel)"},{"key":"2025111909350672000_12.2.e001726.3","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.kint.2019.07.018","article-title":"Kidney biopsy-based management of maintenance immunosuppression is safe and may ameliorate flare rate in lupus nephritis","volume":"97","author":"Malvar","year":"2020","journal-title":"Kidney Int"},{"key":"2025111909350672000_12.2.e001726.4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.kint.2023.09.001","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis","volume":"105","author":"Rovin","year":"2024","journal-title":"Kidney Int"},{"key":"2025111909350672000_12.2.e001726.5","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18028","article-title":"Clinical outcomes in lupus nephritis patients treated with belimumab in real-life setting: a retrospective comparative study in China","volume":"12","author":"Lin","year":"2024","journal-title":"PeerJ"},{"key":"2025111909350672000_12.2.e001726.6","doi-asserted-by":"crossref","first-page":"2885","DOI":"10.1007\/s00296-023-05497-x","article-title":"Kidney histopathology in predicting flares following drug withdrawal in proliferative lupus nephritis in clinical remission","volume":"44","author":"Gopal","year":"2024","journal-title":"Rheumatol Int"},{"key":"2025111909350672000_12.2.e001726.7","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2021-000489","article-title":"Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis","volume":"8","author":"Helget","year":"2021","journal-title":"Lupus Sci Med"},{"key":"2025111909350672000_12.2.e001726.8","doi-asserted-by":"crossref","first-page":"103810","DOI":"10.1016\/j.autrev.2025.103810","article-title":"Lupus nephritis trials network (LNTN) repeat kidney biopsy-based definitions of treatment response: A systematic literature review-based proposal","volume":"24","author":"Parodis","year":"2025","journal-title":"Autoimmun Rev"},{"key":"2025111909350672000_12.2.e001726.9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.23876\/j.krcp.22.083","article-title":"Histologic evaluation of activity and chronicity of lupus nephritis and its clinical significance","volume":"42","author":"Choi","year":"2023","journal-title":"Kidney Res Clin Pract"},{"key":"2025111909350672000_12.2.e001726.10","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2017.07.007"},{"key":"2025111909350672000_12.2.e001726.11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jmii.2017.11.003","article-title":"Role of tubulointerstitial lesions in predicting renal outcome among pediatric onset lupus nephritis \u2013 A retrospective cohort study","volume":"53","author":"Wu","year":"2020","journal-title":"Journal of Microbiology, Immunology and Infection"},{"key":"2025111909350672000_12.2.e001726.12","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.220345"},{"key":"2025111909350672000_12.2.e001726.13","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2010.13"},{"key":"2025111909350672000_12.2.e001726.14","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2025-001578","article-title":"Total Tubulointerstitial Score: a simple and effective predictor of long-term mortality and adverse renal outcomes in lupus nephritis","volume":"12","author":"Zhang","year":"2025","journal-title":"Lupus Sci Med"},{"key":"2025111909350672000_12.2.e001726.15","doi-asserted-by":"crossref","first-page":"103422","DOI":"10.1016\/j.autrev.2023.103422","article-title":"Is per-protocol kidney biopsy required in lupus nephritis?","volume":"23","author":"Parodis","year":"2024","journal-title":"Autoimmun Rev"},{"key":"2025111909350672000_12.2.e001726.16","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfv296"},{"key":"2025111909350672000_12.2.e001726.17","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keaa129"},{"key":"2025111909350672000_12.2.e001726.18","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2020-000389","article-title":"Prediction of prognosis and renal outcome in lupus nephritis","volume":"7","author":"Parodis","year":"2020","journal-title":"Lupus Sci Med"},{"key":"2025111909350672000_12.2.e001726.19","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/art.39623","article-title":"Development of Biomarker Models to Predict Outcomes in Lupus Nephritis","volume":"68","author":"Wolf","year":"2016","journal-title":"Arthritis & Rheumatology"},{"key":"2025111909350672000_12.2.e001726.20","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1093\/rheumatology\/keae509","article-title":"Development and validation of a nomogram for predicting the interstitial fibrosis and tubular atrophy in patients with lupus nephritis","volume":"64","author":"Wang","year":"2025","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2025111909350672000_12.2.e001726.21","doi-asserted-by":"crossref","first-page":"108966","DOI":"10.1016\/j.intimp.2022.108966","article-title":"Clinical predictive model to estimate probability of remission in patients with lupus nephritis","volume":"110","author":"Kang","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"2025111909350672000_12.2.e001726.22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/ndt\/gfad191","article-title":"A nomogram predicting the histologic activity of lupus nephritis from clinical parameters","volume":"39","author":"Gao","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2025111909350672000_12.2.e001726.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2017.11.023"},{"key":"2025111909350672000_12.2.e001726.24","doi-asserted-by":"publisher","DOI":"10.1097\/01.ASN.0000108969.21691.5D"},{"key":"2025111909350672000_12.2.e001726.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248"},{"key":"2025111909350672000_12.2.e001726.26","first-page":"371","article-title":"RENAL INVOLVEMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE)","volume":"57","author":"Appel","year":"1978","journal-title":"Medicine (Abingdon)"},{"key":"2025111909350672000_12.2.e001726.27","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2021.05.021"},{"key":"2025111909350672000_12.2.e001726.28","doi-asserted-by":"crossref","DOI":"10.1136\/lupus-2022-000689","article-title":"Clinical and histological findings at second but not at first kidney biopsy predict end-stage kidney disease in a large multicentric cohort of patients with active lupus nephritis","volume":"9","author":"Gatto","year":"2022","journal-title":"Lupus Sci Med"},{"key":"2025111909350672000_12.2.e001726.29","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/annrheumdis-2016-eular.5689","article-title":"AB0017 Pilot Study on The Patterns of B Lymphocyts Infiltration in Kidney from Patients with Lupus Nephritis","volume":"75","author":"Dong","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2025111909350672000_12.2.e001726.30","doi-asserted-by":"publisher","DOI":"10.1016\/j.ekir.2022.09.012"},{"key":"2025111909350672000_12.2.e001726.31","doi-asserted-by":"crossref","DOI":"10.1007\/s11926-021-00984-1","article-title":"A Review of Complement Activation in SLE","volume":"23","author":"Weinstein","year":"2021","journal-title":"Curr Rheumatol Rep"},{"key":"2025111909350672000_12.2.e001726.32","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1080\/07853890.2023.2187076","article-title":"Significance of co-positivity for anti-dsDNA, -nucleosome, and -histone antibodies in patients with lupus nephritis","volume":"55","author":"Choi","year":"2023","journal-title":"Ann Med"},{"key":"2025111909350672000_12.2.e001726.33","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.autrev.2010.09.002","article-title":"Antibodies to ribosomal P proteins in lupus nephritis: a surrogate marker for a better renal survival?","volume":"10","author":"de Macedo","year":"2011","journal-title":"Autoimmun Rev"},{"key":"2025111909350672000_12.2.e001726.34","doi-asserted-by":"crossref","unstructured":"Deka P , Satish S , Chandrashekar M , et al . Clinicopathological Assessment of Modified Activity and Chronicity Indices in Lupus Nephritis at a Teaching Hospital in Mysore, India. JCDR 2024. doi:10.7860\/JCDR\/2024\/65158.19201","DOI":"10.7860\/JCDR\/2024\/65158.19201"},{"key":"2025111909350672000_12.2.e001726.35","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.140415"},{"key":"2025111909350672000_12.2.e001726.36","first-page":"580","article-title":"Urinary sediment suggests lupus nephritis histology","volume":"26","author":"Mart\u00ednez-Mart\u00ednez","year":"2017","journal-title":"Lupus (Los Angel)"},{"key":"2025111909350672000_12.2.e001726.37","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25168981","article-title":"Lupus Nephritis from Pathogenesis to New Therapies: An Update","volume":"25","author":"Roveta","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2025111909350672000_12.2.e001726.38","doi-asserted-by":"crossref","first-page":"3571","DOI":"10.1093\/rheumatology\/keaf015","article-title":"Nomogram for predicting proliferative lupus nephritis in patients with low-level proteinuria","volume":"64","author":"Lu","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2025111909350672000_12.2.e001726.39","doi-asserted-by":"publisher","DOI":"10.1038\/nrneph.2017.85"},{"key":"2025111909350672000_12.2.e001726.40","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2005070757"},{"key":"2025111909350672000_12.2.e001726.41","doi-asserted-by":"publisher","DOI":"10.1159\/000314656"},{"key":"2025111909350672000_12.2.e001726.42","doi-asserted-by":"crossref","DOI":"10.1007\/s00018-024-05136-z","article-title":"Caspase-11\/GSDMD contributes to the progression of hyperuricemic nephropathy by promoting NETs formation","volume":"81","author":"Wu","year":"2024","journal-title":"Cell Mol Life Sci"},{"key":"2025111909350672000_12.2.e001726.43","doi-asserted-by":"crossref","DOI":"10.1038\/s41392-023-01379-7","article-title":"Kidney fibrosis: from mechanisms to therapeutic medicines","volume":"8","author":"Huang","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"2025111909350672000_12.2.e001726.44","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keu343"},{"key":"2025111909350672000_12.2.e001726.45","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.kint.2024.09.007","article-title":"Urinary biomarkers for active Lupus Nephritis that have survived independent validation across cohorts","volume":"106","author":"Vodehnal","year":"2024","journal-title":"Kidney Int"},{"key":"2025111909350672000_12.2.e001726.46","doi-asserted-by":"crossref","first-page":"5759","DOI":"10.3390\/jcm11195759","article-title":"Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature","volume":"11","author":"Palazzo","year":"2022","journal-title":"J Clin Med"}],"container-title":["Lupus Science &amp; Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/lupus-2025-001726","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T17:35:18Z","timestamp":1763573718000},"score":1,"resource":{"primary":{"URL":"https:\/\/lupus.bmj.com\/lookup\/doi\/10.1136\/lupus-2025-001726"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7]]},"references-count":46,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,11,19]]},"published-print":{"date-parts":[[2025,7]]}},"alternative-id":["10.1136\/lupus-2025-001726"],"URL":"https:\/\/doi.org\/10.1136\/lupus-2025-001726","relation":{},"ISSN":["2053-8790"],"issn-type":[{"value":"2053-8790","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7]]}}}